STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 90 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 15.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $125,000 | -49.4% | 13,138 | -11.7% | 0.00% | – |
| Q3 2018 | $247,000 | +9.8% | 14,879 | +6.0% | 0.00% | – |
| Q2 2018 | $225,000 | +4.7% | 14,043 | 0.0% | 0.00% | – |
| Q1 2018 | $215,000 | -1.8% | 14,043 | 0.0% | 0.00% | – |
| Q4 2017 | $219,000 | +3.3% | 14,043 | -26.4% | 0.00% | – |
| Q3 2017 | $212,000 | -9.8% | 19,074 | -25.4% | 0.00% | – |
| Q2 2017 | $235,000 | +7.3% | 25,562 | 0.0% | 0.00% | – |
| Q1 2017 | $219,000 | +68.5% | 25,562 | +145.8% | 0.00% | – |
| Q3 2014 | $130,000 | -57.4% | 10,400 | -50.0% | 0.00% | -100.0% |
| Q2 2014 | $305,000 | – | 20,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|